New Delhi (India), February 15: Veerhealth Care Limited (BSE – 511523), a leading provider of Ayurvedic, Herbal & Cosmetics healthcare and personal care products under the brand “Ayuveer,”, announced its Unaudited Financial Results for the Q3 & 9M FY24.
9M FY24 Key Financials at a Glance:
• Total Income of ₹ 1107.95 Lakhs YoY growth of 5.48%
• EBITDA of ₹ 162.69 Lakhs YoY growth of 45.74%
• EBITDA Margin of 14.68% YoY growth of 406 BPS
• Net Profit of ₹ 89.32 Lakhs YoY growth of 67.36%
• Net Profit Margin (%) of 8.36% YoY growth of 303 BPS
Commenting on the performance, Mr. Bhavin Shah -Managing Director of Veerhealth Care Limited said, “We’re delighted to report strong financial performance, with a 45% and 67% growth in profitability, showcasing our operational efficiency and effective business strategy. Our dedication to delivering top-notch Ayurvedic, Herbal & Cosmetics healthcare and personal care products has fueled substantial revenue and profit growth. This achievement is a testament to our commitment to providing holistic wellness solutions while upholding the highest standards of quality and compliance.
Moreover, receiving the US FDA labeller code allocation is a significant milestone that reinforces our commitment to quality and regulatory excellence. This accomplishment further propels us towards our goal of delivering premium healthcare solutions on a global scale, ensuring that our customers receive nothing but the best.”
If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.
